
Sign up to save your podcasts
Or


Hosts:
Joseph Snyder
Head of Talent and Co-Founder, Lifeblood
https://www.linkedin.com/in/josephasnyder1/
Cristiano Fontana
Head of Advisory, Lifeblood
https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/
Guests:
Kavita Bouknight
CEO, Match Health Collective
Kavita Bouknight is the CEO of Match Health Collective which specializes in MedTech marketing, messaging, and design. Their work focuses on building compelling brand identities, developing cohesive visual design, crafting strategic messaging frameworks, and creating pitch-ready content and go-to-market strategies to drive visibility and accelerate adoption.
https://www.linkedin.com/in/kavitabouknight/
Martin Gomez
Partner, Goodwin
Co-leading the MedTech and Artificial Intelligence practice across IP, company formation, licensing, fundraising, an strategic transactions or exits.
From FDA expectations to real-world applications, we explore what’s hype, what’s real, and what founders need to know to integrate AI responsibly. Tune in as they explore how AI is shaping product development, regulatory hurdles, and investor expectations across the MedTech landscape.
https://www.linkedin.com/in/martin-gomez-898556113/
By Lifeblood.comHosts:
Joseph Snyder
Head of Talent and Co-Founder, Lifeblood
https://www.linkedin.com/in/josephasnyder1/
Cristiano Fontana
Head of Advisory, Lifeblood
https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/
Guests:
Kavita Bouknight
CEO, Match Health Collective
Kavita Bouknight is the CEO of Match Health Collective which specializes in MedTech marketing, messaging, and design. Their work focuses on building compelling brand identities, developing cohesive visual design, crafting strategic messaging frameworks, and creating pitch-ready content and go-to-market strategies to drive visibility and accelerate adoption.
https://www.linkedin.com/in/kavitabouknight/
Martin Gomez
Partner, Goodwin
Co-leading the MedTech and Artificial Intelligence practice across IP, company formation, licensing, fundraising, an strategic transactions or exits.
From FDA expectations to real-world applications, we explore what’s hype, what’s real, and what founders need to know to integrate AI responsibly. Tune in as they explore how AI is shaping product development, regulatory hurdles, and investor expectations across the MedTech landscape.
https://www.linkedin.com/in/martin-gomez-898556113/